1 year return (CAGR)
2.32%
Supriya Lifescience Limited Exchange (NSE, INR)
SUPRIYA.NSE
-
+21.10 (+2.91%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
46.86%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
60.14B
Price/Sales
8.42
Ent value
60.36B
Price/Book
5.56
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
32.98
PEG
-
Forward P/E
24.26
EPS growth
-4.06%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 729.80 |
| Daily high | 755.00 |
| Daily low | 727.80 |
| Daily Volume | 108K |
| 1y analyst estimate | 850.00 |
| Beta | 0.27 |
| EPS (TTM) | 22.66 |
| Dividend per share | 0.00 |
| Ex-div date | 4 Sep 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SUPRIYA.NSE | S&P500 | |
| Current price drop from All-time high | -7.38% | -0.89% |
| Highest price drop | -69.15% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -31.92% | -10.68% |
| Avg time to new high | 53 days | 12 days |
| Max time to new high | 649 days | 1805 days |
News
No items found